Skip to main content

Table 3 Multinomial logistic analysis

From: Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients

 

RIF

Survival

 

OR (CI)

p Value

OR (CI)

p Value

Control group:

    

Non-diabetics

    

Aprotinin

0.9 (0.4 to 2.2)

0.79

2.3 (0.5 to 11.2)

0.30

ACE inihibitors

1.0 (0.6 to 1.8)

0.94

0.7 (0.2 to 2.8)

0.60

Transfusion

0.9 (0.5 to 1.7)

0.79

0.8 (0.1 to 5.9)

0.69

Diabetics

    

Aprotinin

0.9 (0.3 to 2.8)

0.94

0.5 (0.2 to 1.4)

0.32

ACE inihibitors

1.4 (0.5 to 3.6)

0.52

12.6 (1.4 to 109.2)

0.02

Transfusion

1.6 (0.5 to 5.9)

0.4

0.7 (0.07 to 7.3)

0.77

Insulin group:

    

Non-diabetics

    

Aprotinin

0.7 (0.4 to 1.1)

0.14

2.0 (0.5 to 9.7)

0.39

ACE inihibitors

0.4 (0.3 to 0.5)

0.001

0.7 (0.2 to 3.1)

0.70

Transfusion

0.7 (0.5 to 1.1)

0.15

1.0 (0.6 to 2.9)

0.58

Diabetics

    

Aprotinin

1.0 (0.3 to 2.8)

0.97

1.7 (0.3 to 5.8)

0.26

ACE inihibitors

1.2 (0.7 to 2.3)

0.65

3.4 (1.2 to 12.3)

0.001

Transfusion

1.5 (0.8 to 3.0)

0.25

1.0 (0.8 to 1.1)

0.92

  1. ACE, angiotensin-converting enzyme; CI, confidence interval; OR, odds ratio; RIF, renal failure according to RIFLE (Risk of renal failure, Injury to kidney function, Failure of kidney function, Loss of kidney function and End-stage renal failure) score criteria.